Valuation: Novartis AG

Market Cap 27TCr 24TCr 22TCr 20TCr 38TCr 25,71200Cr 38TCr 2,68100Cr 1,04300Cr 13,12300Cr 1,00200Cr 98TCr 42,18100Cr P/E 2026 *
19.8x
P/E 2027 * 16.6x
Enterprise Value 30TCr 27TCr 25TCr 23TCr 42TCr 28,73600Cr 43TCr 2,99600Cr 1,16600Cr 14,66600Cr 1,12000Cr 1,09600Cr 47,14300Cr EV / Sales 2026 *
5.17x
EV / Sales 2027 * 4.81x
Free-Float
91.66%
Yield 2026 *
3.09%
Yield 2027 * 3.23%
1 day-0.09%
1 week-2.77%
Current month-2.90%
1 month-10.11%
3 months-8.94%
6 months-5.45%
Current year+6.28%
1 week 115.94
Extreme 115.94
122.54
1 month 110.3
Extreme 110.3
127.22
Current year 107.68
Extreme 107.68
132.68
1 year 97.05
Extreme 97.05
132.68
3 years 81.1
Extreme 81.1
132.68
5 years 72.84
Extreme 72.84
132.68
10 years 65.09
Extreme 65.09
132.68
Manager TitleAgeSince
Chief Executive Officer 50 01/02/2018
Director of Finance/CFO - 16/03/2026
Compliance Officer 58 14/04/2025
Director TitleAgeSince
Director/Board Member 67 01/01/2015
Director/Board Member 69 01/01/2016
Director/Board Member 61 01/01/2016
Date Insider Type Main position Quantity % Market Cap. Importance
18/05/26 Sell -5,200 0.0003%
04/05/26 Sell 6,800 0.0003%
17/02/26 Sell 30,743 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
+0.12%-2.77%+10.70%+32.97% 27TCr
+0.02%-3.41%+36.11%+115.09% 1,01900Cr
-1.21%-6.74%+34.08%+62.64% 62TCr
+1.12%+0.54%+13.62%+79.94% 46TCr
-3.30%-6.21%+56.45%+36.58% 36TCr
+0.93%-3.16%+21.65%+43.02% 33TCr
-0.89%-6.28%-7.00%+8.01% 24TCr
-0.01%-2.81%+35.28%+51.82% 22TCr
-0.08%-4.17%+28.34%+93.51% 18TCr
-0.78%-2.45%-34.86%-61.12% 17TCr
Average -0.77%-3.36%+19.44%+46.25% 38.63TCr
Weighted average by Cap. -0.55%-3.46%+25.78%+64.48%

Financials

2026 *2027 *
Net sales 5.77TCr 5.15TCr 4.8TCr 4.36TCr 8.22TCr 5,55700Cr 8.28TCr 58TCr 23TCr 2,83600Cr 22TCr 21TCr 9,11600Cr 6.14TCr 5.48TCr 5.1TCr 4.65TCr 8.75TCr 5,91500Cr 8.81TCr 62TCr 24TCr 3,01900Cr 23TCr 23TCr 9,70400Cr
Net income 1.43TCr 1.27TCr 1.18TCr 1.08TCr 2.03TCr 1,37300Cr 2.05TCr 14TCr 5.57TCr 70TCr 5.35TCr 5.24TCr 2,25300Cr 1.58TCr 1.41TCr 1.31TCr 1.19TCr 2.25TCr 1,52100Cr 2.27TCr 16TCr 6.17TCr 78TCr 5.93TCr 5.8TCr 2,49600Cr
Net Debt 3.14TCr 2.8TCr 2.61TCr 2.38TCr 4.47TCr 3,02400Cr 4.51TCr 32TCr 12TCr 1,54400Cr 12TCr 12TCr 4,96100Cr 2.82TCr 2.52TCr 2.35TCr 2.13TCr 4.02TCr 2,71800Cr 4.05TCr 28TCr 11TCr 1,38700Cr 11TCr 10TCr 4,45900Cr
Logo Novartis AG
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - oncology (30.9%); - immunology (18.9%); - cardiovascular, renal and metabolic diseases (16.4%); - neuroscience (11%). The remaining net sales (22.8%) are from contract manufacturing of pharmaceutical products. At the end of 2025, Novartis AG had over 31 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (2.6%), Europe (28.1%), the United States (42.8%), Asia/Africa/Australasia (19.8%), Canada and Latin America (6.7%).
Employees
75,267
Date Price Change Volume
05/26/05 CHF 116.48 +0.12% 24,07,594
02/26/02 CHF 116.34 -1.46% 25,95,469
01/26/01 CHF 118.06 -1.58% 28,20,997
30/26/30 CHF 119.96 -0.79% 42,58,547
29/26/29 CHF 120.92 -0.40% 26,43,402
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
23
Last Close Price
140.29USD
Average target price
151.69USD
Spread / Average Target
+8.13%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NOVN Stock